Evidence map›Paper›PMID 25100835›Full record

ArticleJournal of virology2014

Inhibition of the human respiratory syncytial virus small hydrophobic protein and structural variations in a bicelle environment.

Yan Li, Janet To, Carmina Verdià-Baguena, Silvia Dossena, Wahyu Surya, Mei Huang, Markus Paulmichl, Ding Xiang Liu, Vicente M Aguilella, Jaume Torres

Open access · bronzeAbstract read
In one paragraph

Article in Journal of virology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
5.1field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 49 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Review
  9. Human respiratory syncytial virus: pathogenesis, immune responses, and current vaccine approaches.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2018
    Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Targeting the Channel Activity of Viroporins.Advances in protein chemistry and structural biology · 2016
    Review
  15. Review
  16. Review
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 3 countries.

Yan LiSchool of Biological Sciences, Nanyang Technological University, Singapore.
Janet ToSchool of Biological Sciences, Nanyang Technological University, Singapore.
Carmina Verdià-BaguenaDepartment of Physics, Universitat Jaume I, Castellon, Spain.
Silvia DossenaInstitute of Pharmacology and Toxicology, Paracelsus Medical University, Salzburg, Austria.
Wahyu SuryaSchool of Biological Sciences, Nanyang Technological University, Singapore.
Mei HuangSchool of Biological Sciences, Nanyang Technological University, Singapore.
Markus PaulmichlInstitute of Pharmacology and Toxicology, Paracelsus Medical University, Salzburg, Austria.
Ding Xiang LiuSchool of Biological Sciences, Nanyang Technological University, Singapore.
Vicente M AguilellaDepartment of Physics, Universitat Jaume I, Castellon, Spain.
Jaume TorresSchool of Biological Sciences, Nanyang Technological University, Singapore jtorres@ntu.edu.sg.
Nanyang Technological University · SGParacelsus Medical University · ATUniversitat Jaume I · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The small hydrophobic (SH) protein is a 64-amino-acid polypeptide encoded by the human respiratory syncytial virus (hRSV). SH protein has a single α-helical transmembrane (TM) domain that forms pentameric ion channels. Herein, we report the first inhibitor of the SH protein channel, pyronin B, and we have mapped its binding site to a conserved surface of the RSV SH pentamer, at the C-terminal end of the transmembrane domain. The validity of the SH protein structural model used has been confirmed by using a bicellar membrane-mimicking environment. However, in bicelles the α-helical stretch of the TM domain extends up to His-51, and by comparison with previous models both His-22 and His-51 adopt an interhelical/lumenal orientation relative to the channel pore. Neither His residue was found to be essential for channel activity although His-51 protonation reduced channel activity at low pH, with His-22 adopting a more structural role. The latter results are in contrast with previous patch clamp data showing channel activation at low pH, which could not be reproduced in the present work. Overall, these results establish a solid ground for future drug development targeting this important viroporin. Importance: The human respiratory syncytial virus (hRSV) is responsible for 64 million reported cases of infection and 160,000 deaths each year. Lack of adequate antivirals fuels the search for new targets for treatment. The small hydrophobic (SH) protein is a 64-amino-acid polypeptide encoded by hRSV and other paramyxoviruses, and its absence leads to viral attenuation in vivo and early apoptosis in infected cells. SH protein forms pentameric ion channels that may constitute novel drug targets, but no inhibitor for this channel activity has been reported so far. A small-molecule inhibitor, pyronin B, can reduce SH channel activity, and its likely binding site on the SH protein channel has been identified. Black lipid membrane (BLM) experiments confirm that protonation of both histidine residues reduces stability and channel activity. These results contrast with previous patch clamp data that showed low-pH activation, which we have not been able to reproduce.

Indexed as

Lipid BilayersAmino Acid SequenceAnimalsBinding SitesChlorocebus aethiopsCloning, MolecularGenes, ViralHydrophobic and Hydrophilic InteractionsMolecular Sequence DataNuclear Magnetic Resonance, BiomolecularPatch-Clamp TechniquesPyronineRespiratory Syncytial VirusesVero CellsViral Plaque AssayViral ProteinsLipid BilayersPyroninepyronine BViral Proteins

Identifiers

PMID25100835
PMCPMC4178740
OpenAlexW2098918223

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.